<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36776879</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia.</ArticleTitle><Pagination><StartPage>1101808</StartPage><MedlinePgn>1101808</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1101808</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1101808</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Despite of massive endeavors to characterize inflammation in COVID-19 patients, the core network of inflammatory mediators responsible for severe pneumonia stillremain remains elusive.</AbstractText><AbstractText Label="METHODS">Here, we performed quantitative and kinetic analysis of 191 inflammatory factors in 955 plasma samples from 80 normal controls (sample n = 80) and 347 confirmed COVID-19 pneumonia patients (sample n = 875), including 8 deceased patients.</AbstractText><AbstractText Label="RESULTS">Differential expression analysis showed that 76% of plasmaproteins (145 factors) were upregulated in severe COVID-19 patients comparedwith moderate patients, confirming overt inflammatory responses in severe COVID-19 pneumonia patients. Global correlation analysis of the plasma factorsrevealed two core inflammatory modules, core I and II, comprising mainly myeloid cell and lymphoid cell compartments, respectively, with enhanced impact in a severity-dependent manner. We observed elevated IFNA1 and suppressed IL12p40, presenting a robust inverse correlation in severe patients, which was strongly associated with persistent hyperinflammation in 8.3% of moderate pneumonia patients and 59.4% of severe patients.</AbstractText><AbstractText Label="DISCUSSION">Aberrant persistence of pulmonary and systemic inflammation might be associated with long COVID-19 sequelae. Our comprehensive analysis of inflammatory mediators in plasmarevealed the complexity of pneumonic inflammation in COVID-19 patients anddefined critical modules responsible for severe pneumonic progression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Jeon, Kim, Kang, Park, Kim, Park, Koh, Shim, Kim, Rhee, Jeong, Lee, Park, Lim, Kim, Ha, Jo, Kim, Lee, Shon, Kim, Jeon, Choi, Kim, Lee, Choi, Park, Park, Kim and Cho.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Kyeongseok</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Shin Kwang</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Chungnam National University School of Medicine, Deajon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Uni</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jayoun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Nanhee</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Jaemoon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Man-Shik</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Chungnam National University School of Medicine, Deajon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minsoo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Youn Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Chungnam National University School of Medicine, Deajon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Hyeongseok</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Chungnam National University School of Medicine, Deajon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Siyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Geninus Inc., Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Donghyun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Geninus Inc., Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jinyoung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyunsu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Na-Young</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Chungnam National University Hospital, Biomedical Research Institute, Deajon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Hye-Yeong</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sang Cheol</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ju-Hee</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shon</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biohealth Regulatory Science, School of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hoon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biohealth Regulatory Science, School of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biopharmaceutical Convergence Major, School of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Yoon Kyung</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Youn-Soo</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hye Young</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Won-Woo</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Murim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hyun-Young</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Woong-Yang</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Geninus Inc., Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yeon-Sook</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Chungnam National University School of Medicine, Deajon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Nam-Hyuk</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Endemic Diseases, Medical Research Center, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wide River Institute of Immunology, Seoul National University, Hongcheon, Gangwon-do, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554156">IFNA1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Immunol. 2023 Mar 08;14:1175767. doi: 10.3389/fimmu.2023.1175767</RefSource><PMID Version="1">36969212</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">IFNa</Keyword><Keyword MajorTopicYN="N">IL-12p40</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">pneumonia</Keyword></KeywordList><CoiStatement>SL, DP and W-YP are employed by Geninus Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>13</Day><Hour>3</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36776879</ArticleId><ArticleId IdType="pmc">PMC9911526</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1101808</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. (2022) 375(6585):1122&#x2013;7. doi: 10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol (2022) 7(67):eabm5505. doi: 10.1126/sciimmunol.abm5505</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abm5505</ArticleId><ArticleId IdType="pubmed">34995097</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson PC, Liew DFL, Tanner HL, Grainger JR, Dwek RA, Reisler RB, et al. . COVID-19 therapeutics: Challenges and directions for the future. Proc Natl Acad Sci U S A. (2022) 119(15):e2119893119. doi: 10.1073/pnas.2119893119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2119893119</ArticleId><ArticleId IdType="pmc">PMC9169797</ArticleId><ArticleId IdType="pubmed">35385354</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation Management of COVID-Infection . A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis (2020) 20(8):e192&#x2013;e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DM, Kim Y, Seo JW, Lee J, Park U, Ha NY, et al. . Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19. Cell Rep (2021) 37(1):109798. doi: 10.1016/j.celrep.2021.109798</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109798</ArticleId><ArticleId IdType="pmc">PMC8450316</ArticleId><ArticleId IdType="pubmed">34587481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T, Kim Y, Kim HJ, Ha NY, Lee S, Chin B, et al. . Acute surge of atypical memory and plasma b-cell subsets driven by an extrafollicular response in severe COVID-19. Front Cell Infect Microbiol (2022) 12:909218. doi: 10.3389/fcimb.2022.909218</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.909218</ArticleId><ArticleId IdType="pmc">PMC9309264</ArticleId><ArticleId IdType="pubmed">35899045</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. . Massively parallel digital transcriptional profiling of single cells. Nat Commun (2017) 8:14049. doi: 10.1038/ncomms14049</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14049</ArticleId><ArticleId IdType="pmc">PMC5241818</ArticleId><ArticleId IdType="pubmed">28091601</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Hao S, Andersen-Nissen E, Mauck WM, 3rd, Zheng S, Butler A, et al. . Integrated analysis of multimodal single-cell data. Cell. (2021) 184(13):3573&#x2013;87 e29. doi: 10.1016/j.cell.2021.04.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.048</ArticleId><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu ZG, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. (2016) 32(18):2847&#x2013;9. doi: 10.1093/bioinformatics/btw313</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu GC, Wang LG, Han YY, He QY. clusterProfiler: an r package for comparing biological themes among gene clusters. Omics. (2012) 16(5):284&#x2013;7. doi: 10.1089/omi.2011.0118</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinf (2013) 14:128. doi: 10.1186/1471-2105-14-128</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginestet C. ggplot2: Elegant graphics for data analysis. J R Stat Soc Ser A. (2011) 174:245. doi: 10.1111/j.1467-985X.2010.00676_9.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-985X.2010.00676_9.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Cheon S, Jeong H, Park U, Ha NY, Lee J, et al. . Differential association of viral dynamics with disease severity depending on patients' age group in COVID-19. Front Microbiol (2021) 12:712260. doi: 10.3389/fmicb.2021.712260</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.712260</ArticleId><ArticleId IdType="pmc">PMC8343133</ArticleId><ArticleId IdType="pubmed">34367117</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam PS, Wimmers F, Mok CKP, Perera R, Scott M, Hagan T, et al. . Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. (2020) 369(6508):1210&#x2013;20. doi: 10.1126/science.abc6261</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6261</ArticleId><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. . Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. (2020) 182(1):59&#x2013;72 e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, et al. . A time-resolved proteomic and prognostic map of COVID-19. Cell Syst (2021) 12(8):780&#x2013;94.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8201874</ArticleId><ArticleId IdType="pubmed">34139154</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, et al. . Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep Med (2021) 2(5):100287. doi: 10.1016/j.xcrm.2021.100287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100287</ArticleId><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, De Jesus AAA, et al. . An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight (2021) 6(1):e144455. doi: 10.1172/jci.insight.144455</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.144455</ArticleId><ArticleId IdType="pmc">PMC7821609</ArticleId><ArticleId IdType="pubmed">33232303</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann C, Takov K, Burnap SA, Singh B, Ali H, Theofilatos K, et al. . SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun (2021) 12(1):3406. doi: 10.1038/s41467-021-23494-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23494-1</ArticleId><ArticleId IdType="pmc">PMC8184784</ArticleId><ArticleId IdType="pubmed">34099652</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Ontology Consortium . The gene ontology resource: enriching a GOld mine. Nucleic Acids Res (2021) 49(D1):D325&#x2013;D34. doi: 10.1093/nar/gkaa1113</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1113</ArticleId><ArticleId IdType="pmc">PMC7779012</ArticleId><ArticleId IdType="pubmed">33290552</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst (2015) 1(6):417&#x2013;25. doi: 10.1016/j.cels.2015.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong LR, Perlman S. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses - are we our own worst enemy? Nat Rev Immunol (2022) 22(1):47&#x2013;56. doi: 10.1038/s41577-021-00656-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00656-2</ArticleId><ArticleId IdType="pmc">PMC8617551</ArticleId><ArticleId IdType="pubmed">34837062</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol (2020) 20(6):363&#x2013;74. doi: 10.1038/s41577-020-0311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. . Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med (2020) 26(6):842&#x2013;4. doi: 10.1038/s41591-020-0901-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, et al. . COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol (2020) 38(8):970&#x2013;9. doi: 10.1038/s41587-020-0602-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0602-4</ArticleId><ArticleId IdType="pubmed">32591762</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridges JP, Vladar EK, Huang H, Mason RJ. Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19. Thorax. (2022) 77(2):203&#x2013;9. doi: 10.1136/thoraxjnl-2021-217561</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217561</ArticleId><ArticleId IdType="pmc">PMC9273148</ArticleId><ArticleId IdType="pubmed">34404754</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadras O, Afsahi AM, Pashaei Z, Mojdeganlou H, Karimi A, Habibi P, et al. . The relationship between COVID-19 viral load and disease severity: A systematic review. Immun Inflammation Dis (2022) 10(3):e580. doi: 10.1002/iid3.580</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.580</ArticleId><ArticleId IdType="pmc">PMC8926507</ArticleId><ArticleId IdType="pubmed">34904379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JS, Yoo MG, Lee HJ, Jang HB, Jung HD, Nam JG, et al. . Factors associated with viral load kinetics of middle east respiratory syndrome coronavirus during the 2015 outbreak in Republic of Korea. J Infect Dis (2021) 223(6):1088&#x2013;92. doi: 10.1093/infdis/jiaa466</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa466</ArticleId><ArticleId IdType="pmc">PMC7454697</ArticleId><ArticleId IdType="pubmed">32761054</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. . Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet. (2003) 361(9371):1767&#x2013;72. doi: 10.1016/S0140-6736(03)13412-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13412-5</ArticleId><ArticleId IdType="pmc">PMC7112410</ArticleId><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference><Reference><Citation>Messner CB, Demichev V, Wendisch D, Michalick L, White M, Freiwald A, et al. . Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst (2020) 11(1):11&#x2013;24.e4. doi: 10.1016/j.cels.2020.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7264033</ArticleId><ArticleId IdType="pubmed">32619549</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Nesf MAY, Abdesselem HB, Bensmail I, Ibrahim S, Saeed WAH, Mohammed SSI, et al. . Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications. Nat Commun (2022) 13(1):946. doi: 10.1038/s41467-022-28639-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28639-4</ArticleId><ArticleId IdType="pmc">PMC8854716</ArticleId><ArticleId IdType="pubmed">35177642</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer PE, Arend FM, Doll S, Louiset ML, Winter SV, Muller-Reif JB, et al. . High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion. EMBO Mol Med (2021) 13(8):e14167. doi: 10.15252/emmm.202114167</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114167</ArticleId><ArticleId IdType="pmc">PMC8687121</ArticleId><ArticleId IdType="pubmed">34232570</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, et al. . Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity. (2020) 53(5):1108&#x2013;22 e5. doi: 10.1016/j.immuni.2020.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7574896</ArticleId><ArticleId IdType="pubmed">33128875</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisby J, Clarke CL, Medjeral-Thomas N, Malik TH, Papadaki A, Mortimer PM, et al. . Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death. Elife. (2021) 10:e64827. doi: 10.7554/eLife.64827.sa2</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64827.sa2</ArticleId><ArticleId IdType="pmc">PMC8064756</ArticleId><ArticleId IdType="pubmed">33704068</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, et al. . Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. (2021) 54(4):797&#x2013;814 e6. doi: 10.1016/j.immuni.2021.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.03.005</ArticleId><ArticleId IdType="pmc">PMC7951561</ArticleId><ArticleId IdType="pubmed">33765436</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Suryadevara N, Hill TM, Bezbradica JS, Van Kaer L, Joyce S. Natural killer T cells: An ecological evolutionary developmental biology perspective. Front Immunol (2017) 8:1858. doi: 10.3389/fimmu.2017.01858</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01858</ArticleId><ArticleId IdType="pmc">PMC5743650</ArticleId><ArticleId IdType="pubmed">29312339</ArticleId></ArticleIdList></Reference><Reference><Citation>Stock P, Lombardi V, Kohlrautz V, Akbari O. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J Immunol (2009) 182(8):5116&#x2013;22. doi: 10.4049/jimmunol.0804213</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0804213</ArticleId><ArticleId IdType="pmc">PMC2837931</ArticleId><ArticleId IdType="pubmed">19342692</ArticleId></ArticleIdList></Reference><Reference><Citation>Middendorp S, Nieuwenhuis EE. NKT cells in mucosal immunity. Mucosal Immunol (2009) 2(5):393&#x2013;402. doi: 10.1038/mi.2009.99</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2009.99</ArticleId><ArticleId IdType="pubmed">19587641</ArticleId></ArticleIdList></Reference><Reference><Citation>Koay HF, Gherardin NA, Nguyen THO, Zhang W, Habel JR, Seneviratna R, et al. . Are NKT cells a useful predictor of COVID-19 severity? Immunity (2022) 55(2):185&#x2013;7. doi: 10.1016/j.immuni.2022.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.005</ArticleId><ArticleId IdType="pmc">PMC8768020</ArticleId><ArticleId IdType="pubmed">35104438</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma LN, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, et al. . Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci Immunol (2021) 6(59):eabh2259. doi: 10.1126/sciimmunol.abh2259</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh2259</ArticleId><ArticleId IdType="pmc">PMC8158979</ArticleId><ArticleId IdType="pubmed">34446527</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, et al. . Untimely TGFbeta responses in COVID-19 limit antiviral functions of NK cells. Nature. (2021) 600(7888):295&#x2013;301. doi: 10.1038/s41586-021-04142-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04142-6</ArticleId><ArticleId IdType="pubmed">34695836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitopoulou I, Fanidis D, Ntatsoulis K, Moulos P, Mpekoulis G, Evangelidou M, et al. . Increased autotaxin levels in severe COVID-19, correlating with IL-6 levels, endothelial dysfunction biomarkers, and impaired functions of dendritic cells. Int J Mol Sci (2021) 22(18):10006. doi: 10.3390/ijms221810006</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221810006</ArticleId><ArticleId IdType="pmc">PMC8469279</ArticleId><ArticleId IdType="pubmed">34576169</ArticleId></ArticleIdList></Reference><Reference><Citation>Andre S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, et al. . T Cell apoptosis characterizes severe covid-19 disease. Cell Death Differ (2022) 29(8):1486&#x2013;99. doi: 10.1038/s41418-022-00936-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-00936-x</ArticleId><ArticleId IdType="pmc">PMC8782710</ArticleId><ArticleId IdType="pubmed">35066575</ArticleId></ArticleIdList></Reference><Reference><Citation>Quartuccio L, Fabris M, Sonaglia A, Peghin M, Domenis R, Cifu A, et al. . Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia. Cytokine. (2021) 140:155438. doi: 10.1016/j.cyto.2021.155438</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155438</ArticleId><ArticleId IdType="pmc">PMC7810025</ArticleId><ArticleId IdType="pubmed">33493861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YM, Shin EC. Type I and III interferon responses in SARS-CoV-2 infection. Exp Mol Med (2021) 53(5):750&#x2013;60. doi: 10.1038/s12276-021-00592-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00592-0</ArticleId><ArticleId IdType="pmc">PMC8099704</ArticleId><ArticleId IdType="pubmed">33953323</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber G. The role of type I interferons in the pathogenesis and treatment of COVID-19. Front Immunol (2020) 11:595739. doi: 10.3389/fimmu.2020.595739</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.595739</ArticleId><ArticleId IdType="pmc">PMC7561359</ArticleId><ArticleId IdType="pubmed">33117408</ArticleId></ArticleIdList></Reference><Reference><Citation>Floss DM, Moll JM, Scheller J. IL-12 and IL-23-Close relatives with structural homologies but distinct immunological functions. Cells. (2020) 9(10):2184. doi: 10.3390/cells9102184</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102184</ArticleId><ArticleId IdType="pmc">PMC7600943</ArticleId><ArticleId IdType="pubmed">32998371</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber AN, Abdi K, Singh NJ. The subunits of IL-12, originating from two distinct cells, can functionally synergize to protect against pathogen dissemination in vivo. Cell Rep (2021) 37(2):109816. doi: 10.1016/j.celrep.2021.109816</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109816</ArticleId><ArticleId IdType="pmc">PMC8569637</ArticleId><ArticleId IdType="pubmed">34644571</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med (2021) 27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med (2022) 28(7):1461&#x2013;7. doi: 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>